News Releases

Medicine Man Technologies Inc. to Webcast, Live, at VirtualInvestorConferences.com June 7

Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com

DENVER, June 4, 2018 /PRNewswire/ -- Medicine Man Technologies Inc. (OTCQB: MDCL) ("Medicine Man Technologies" or "Company"), one of the United States' leading cannabis branding and consulting companies, today announced that Brett Roper, CEO, will present live at VirtualInvestorConferences.com on June 7, 2018 at 10:30 AM ET.

View investor presentations 24/7 at  www.virtualinvestorconferences.com . (PRNewsFoto/OTC Markets Group Inc.)

DATE: Thursday, June 7, 2018
TIME: 10:30 AM ET
LINK: https://tinyurl.com/0618prepr

This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the association's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register and run the online system check to save time and receive event updates.

Recent Company Highlights

  • In May 2018, Medicine Man reported profitable first quarter 2018 financial results, highlighted by 124% revenue growth, making this the fifth consecutive quarter on quarter revenue growth period achieved
  • In April 2018, Medicine Man reported the addition of five new client license and/or service agreements for the month of March 2018
  • In February 2018, Medicine Man and Solis Tek announced a cooperative agreement to provide its cannabis grower network with leading lighting solutions

The Cannabis Virtual Investor Conference on June 7, 2018 is made possible by a partnership between KCSA Strategic Communications and VirtualInvestorConferences.com.  Learn more about the event at www.VirtualInvestorConferences.com.

To be added to the Medicine Man email distribution list, please email, MDCL@kcsa.com with MDCL in the subject line.

About Medicine Man Technologies, Inc.
Established in March 2014, the Company secured its first client/licensee in April 2014. To date, the Company has provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state. The Company currently has or has had active clients in California, Iowa, Oregon, Colorado, Nevada, Illinois, Michigan, Arkansas, Pennsylvania, Florida, Ohio, Maryland, New York, Massachusetts, Puerto Rico, Canada, Australia, Germany, and South Africa. We continue to focus on working with clients to 1) utilize its experience, technology, and training to help secure a license in states with newly emerging regulations, 2) deploy the Company's highly effective variable capacity constant harvest cultivation practices through its deployment of Cultivation MAX, and eliminate the liability of single grower dependence, 3) avoid the costly mistakes generally made in start-up, 4) stay engaged with an ever expanding team of licensees and partners, all focused on quality and safety that will "share" the ever-improving experience and knowledge of the network, and 5) continuing the expansion of our Brands Warehouse concept through entry into industry based cooperative agreements and pursuing other acquisitions as they prove suitable to our overall business development strategy.

About VirtualInvestorConferences.com
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.

Safe Harbor Statement
This press release may contain forward-looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues and any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the Securities and Exchange Commission. Among other matters, the Medicine Man Technologies may not be able to sustain growth or achieve profitability based on many factors including, but not limited to, general stock market conditions. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC filings. We have incurred and will continue to incur significant expenses in the expansion of our existing and new service lines, noting there is no assurance that we will generate enough revenues to offset those costs in both the near and long-term. Additional service offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations where we will be providing services, the impact of which cannot be predicted at this time.

For more information, visit us at www.medicinemantechnologies.com; www.threealight.com

 

SOURCE Medicine Man Technologies Inc.

For further information: KCSA Strategic Communications, MDCL@kcsa.com; VirtualInvestorConferences.com: John Viglotti, VP, Investor Relations Products and Services, Cision / PR Newswire / MultiVu, +1.201.360.6767, john.viglotti@prnewswire.com